- Home
- ITOS vs ARQQ Comparison
ITOS vs ARQQ Comparison
Compare ITOS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- ARQQ
- Stock Information
- Founded
- ITOS 2011
- ARQQ 2017
- Country
- ITOS United States
- ARQQ United Kingdom
- Employees
- ITOS N/A
- ARQQ N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- ARQQ Computer Software: Prepackaged Software
- Sector
- ITOS Health Care
- ARQQ Technology
- Exchange
- ITOS Nasdaq
- ARQQ Nasdaq
- Market Cap
- ITOS 270.7M
- ARQQ 309.4M
- IPO Year
- ITOS 2020
- ARQQ N/A
- Fundamental
- Price
- ITOS $9.99
- ARQQ $41.45
- Analyst Decision
- ITOS Hold
- ARQQ Strong Buy
- Analyst Count
- ITOS 6
- ARQQ 1
- Target Price
- ITOS $10.60
- ARQQ $52.00
- AVG Volume (30 Days)
- ITOS 1.8M
- ARQQ 1.4M
- Earning Date
- ITOS 08-07-2025
- ARQQ 05-22-2025
- Dividend Yield
- ITOS N/A
- ARQQ N/A
- EPS Growth
- ITOS N/A
- ARQQ N/A
- EPS
- ITOS N/A
- ARQQ 0.48
- Revenue
- ITOS $35,000,000.00
- ARQQ $241,000.00
- Revenue This Year
- ITOS N/A
- ARQQ $1,818.77
- Revenue Next Year
- ITOS N/A
- ARQQ N/A
- P/E Ratio
- ITOS N/A
- ARQQ $86.04
- Revenue Growth
- ITOS 177.89
- ARQQ N/A
- 52 Week Low
- ITOS $4.80
- ARQQ $3.72
- 52 Week High
- ITOS $18.13
- ARQQ $52.79
- Technical
- Relative Strength Index (RSI)
- ITOS 65.96
- ARQQ 76.17
- Support Level
- ITOS $9.93
- ARQQ $23.50
- Resistance Level
- ITOS $10.21
- ARQQ $28.44
- Average True Range (ATR)
- ITOS 0.18
- ARQQ 3.03
- MACD
- ITOS -0.11
- ARQQ 1.25
- Stochastic Oscillator
- ITOS 18.07
- ARQQ 83.95
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.